Does in utero exposure of antiepileptic drugs lead to failure to reach full cognitive potential?

Seizure

Volumn 28, Issue , 2015, Pages 51-56

  McCorry, D ^a   Bromley, R ^b,c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Aspergers and autistic spectrum disorder; Cognitive potential; In utero AED exposure; IQ; Valproate exposure; Women and epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; VALPROIC ACID;

ARTICLE; COGNITIVE DEFECT; EPILEPSY; FETUS OUTCOME; HUMAN; PERINATAL DRUG EXPOSURE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SKILL; CHEMICALLY INDUCED; DEVELOPMENTAL DISORDER; DOSE RESPONSE; FEMALE; PATHOPHYSIOLOGY; PRENATAL EXPOSURE;

ANTICONVULSANTS; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84929267441     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2015.01.019     Document Type: Review

References (55)

1. C. Ikonomidou, and L. Turski Antiepileptic drugs and brain development Epilepsy Res 88 2010 11 22
2. J.W. Olney, D.F. Wozniak, V. Jevtovic-Todorovic, N.B. Farber, P. Bittigau, and C. Ikonomidou Drug-induced apoptotic neurodegeneration in the developing brain Brain Pathol 12 4 2002 488 498
3. T. Tomson, H. Xue, and D. Battino Major congenital malformations in children of women with epilepsy Seizure 28 2015 40 44
4. T. Tomson, D. Battino, E. Bonizzoni, J. Craig, D. Lindhout, and A. Sabers Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry Lancet Neurol 10 2011 609 617
5. S. Hernández-Díaz, C.R. Smith, A. Shen, R. Mittendorf, W.A. Hauser, and M. Yerby Comparative safety of antiepileptic drugs during pregnancy Neurology 78 2012 1692 1699
6. E. Campbell, F. Kennedy, A. Russell, E. Campbell, F. Kennedy, and A. Russell Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers J Neurol Neurosurg Psychiatry 85 2014 1029 1034
7. H.H. Ardinger, J.F. Atkin, R.D. Blackston, L.J. Elsas, S.K. Clarren, and S. Livingstone Verification of the fetal valproate syndrome phenotype Am J Med Genet 29 1988 171 185
8. S.A. Clay, R. McVie, and H. Chen Possible teratogenic effect of valproic acid J Pediatr 99 1981 828
9. B.N.V. Chevallier, E. Bidat, and B. Lagardere Fetal valproate syndrome and somatic and psychomotor development Arch Franc Pediatr 46 1989 627 628
10. P. Bittigau, M. Sifringer, and C. Ikonomidou Antiepileptic drugs and apoptosis in the developing brain Ann N Y Acad Sci 993 2003 103 114
11. J.B. Manent, Y. Ben-Ari, and A. Represa Antiepileptic drugs and pregnancy: brain malformations in rats prenatally exposed to lamotrigine, vigabatrin and valproate Epilepsy 20 1 2008 27 32
12. H. Go, J. Seo, K. Kim, S. Han, P. Kim, and Y. Kang Valproic acid inhibits neural progenitor cell death by activation of NF-kappaB signaling pathway and up-regulation of Bcl-XL J Biomed Sci 18 2011 48
13. A. Sabers, F.C. Bertelsen, J. Scheel-Kruger, J.R. Nyengaard, and A. Moller Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism Neurosci Lett 580 2014 12 16
14. E. Aberg, S. Holst, A. Neagu, S.O. Ogren, and C. Lavebratt Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory PLOS ONE 8 2013 e80497
15. N.S. Marchi, R. Azoubel, and W.A. Tognola Teratogenic effects of lamotrigine on rat fetal brain: a morphometric study Arq Neuropsiquiatr 59 2001 362 364
16. J.S. Kim, A. Kondratyev, Y. Tomita, and K. Gale Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain Epilepsia 48 Suppl. 5 2007 19 26
17. I.J. Deary, A. Pattie, and J.M. Starr The stability of intelligence from age 11 to age 90 years: the Lothian birth cohort of 1921 Psychol Sci 24 2013 2361 2368
18. H.L. Eriksen, U.S. Kesmodel, M. Underbjerg, T.R. Kilburn, J. Bertrand, and E.L. Mortensen Predictors of intelligence at the age of 5: family, pregnancy and birth characteristics, postnatal influences, and postnatal growth PLOS ONE 8 2013 e79200
19. J. Stiles The fundamentals of brain development: integrating nature and nurture 2008 Harvard University Press Cambridge, USA
20. I.J. Deary, S. Strand, P. Smith, and C. Fernandes Intelligence and educational achievement Intelligence 35 2007 13 21
21. E. Whitley, C.R. Gale, I.J. Deary, M. Kivimaki, and G.D. Batty Association of maternal and paternal IQ with offspring conduct, emotional, and attention problem scores. Transgenerational evidence from the 1958 British Birth Cohort Study Arch Gen Psychiatry 68 2011 1032 1038
22. D.W. Wechsler Intelligence scale for children fourth UK edition 2004 The Psychological Corporation San Antonio, Texas
23. L.H. Trahan, K.K. Stuebing, J.M. Fletcher, and M. Hiscock The Flynn effect: a meta-analysis Psychol Bull 140 2014 1332 1360
24. F. Vargha-Khadem, D.G. Gadian, K.E. Watkins, A. Connelly, W. Van Paesschen, and M. Mishkin Differential effects of early hippocampal pathology on episodic and semantic memory Science 277 1997 376 380
25. H. Tanaka, J.M. Black, C. Hulme, L.M. Stanley, S.R. Kesler, and S. Whitfield-Gabrieli The brain basis of the phonological deficit in dyslexia is independent of IQ Psychol Sci 22 2011 1442 1451
26. S.A. Rose, J.F. Feldman, J.J. Jankowski, and R. Van Rossem Information processing from infancy to 11 years: continuities and prediction of IQ Intelligence 40 2012 445 457
27. N. Bayley Bayley scales of infant and toddler development, 3rd edition 2005 The Psychological Corporation San Antonio, Texas
28. M. Huntley The Griffiths mental development scales: from birth to 2 years 2nd ed. 1996 The Test Agency Oxford, UK
29. J.M. Friedman ABCDXXX: the obscenity of postmarketing surveillance for teratogenic effects Birth Defects Res A: Clin Mol Teratol 94 2012 670 676
30. K.J. Meador, G.A. Baker, N. Browning, J. Clayton-Smith, D.T. Combs-Cantrell, and M. Cohen Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs N Engl J Med 360 2009 1597 1605
31. G. Mawer, M. Briggs, G.A. Baker, R. Bromley, H. Coyle, and J. Eatock Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study Seizure: J Br Epilepsy Assoc 19 2010 112 119
32. K.J. Meador, P. Penovich, G.A. Bake, P.B. Pennell, E. Bromfield, and A. Pack Antiepileptic drug use in women of childbearing age Epilepsy Behav 15 2009 339 343
33. Y. Feldman, G. Koren, K. Mattice, H. Shear, E. Pellegrini, and S.M. MacLeod Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy Teratology 40 1989 37 45
34. M. Rockenbauer, J. Olsen, A.E. Czeizel, L. Pedersen, H.T. Sorensen, and M.A.P.G. Euro Recall bias in a case-control surveillance system on the use of medicine during pregnancy Epidemiology 12 2001 461 466
35. R. Bromley, J. Weston, N. Adab, J. Greenhalgh, A. Sanniti, and A.J. McKay Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child Cochrane Database Syst Rev 7 2014 10.1002/14651858.CD010236.pub2 Art. No.: CD010236
36. E. Gaily, E. Kantola-Sorsa, V. Hiilesmaa, M. Isoaho, R. Matila, and M. Kotila Normal intelligence in children with prenatal exposure to carbamazepine Neurology 62 2004 28 32
37. K. Wide, E. Henning, T. Tomson, and B. Winbladh Psychomotor development in preschool children exposed to antiepileptic drugs in utero Acta Paediatr 91 2002 409 414
38. R.L. Bromley, G. Mawer, J. Love, J. Kelly, L. Purdy, and L. McEwan Early cognitive development in children born to women with epilepsy: a prospective report Epilepsia 51 2010 2058 2065
39. N. Adab, U. Kini, J. Vinten, J. Ayres, G. Baker, and J. Clayton-Smith The longer term outcome of children born to mothers with epilepsy J Neurol Neurosurg Psychiatry 75 2004 1575 1583
40. K.J. Meador, G.A. Baker, N. Browning, M.J. Cohen, R. Bromley, and J. Clayton-Smith Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years Neurology 78 2012 1207 1214
41. K.J. Meador, G.A. Baker, N. Browning, M.J. Cohen, R. Bromley, and J. Clayton-Smith Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study Lancet Neurol 12 2013 244 252
42. A.D. Rasalam, H. Hailey, J.H. Williams, S.J. Moore, P.D. Turnpenny, and D.J. Lloyd Characteristics of fetal anticonvulsant syndrome associated autistic disorder Dev Med Child Neurol 47 2005 551 555
43. R.L. Bromley, G.E. Mawer, M. Briggs, C. Cheyne, J. Clayton-Smith, and M. García-Fiñana The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs J Neurol Neurosurg Psychiatry 84 2013 637 643
44. J. Christensen, T.K. Gronborg, M.J. Sorensen, D. Schendel, E.T. Parner, L.H. Pedersen, and M. Vestergaard Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism JAMA 309 2013 1696 1703
45. N. Adab, A. Jacoby, D. Smith, and D. Chadwick Additional educational needs in children born to mothers with epilepsy J Neurol Neurosurg Psychiatry 70 2001 15 21
46. R. Shallcross, R.L. Bromley, C.P. Cheyne, R. Shallcross, M. García-Fiñana, and B. Irwin In utero exposure to levetiracetam vs valproate: development and language at 3 years of age Neurology 82 2014 213 221
47. R. Shallcross, R.L. Bromley, B. Irwin, L.J. Bonnett, J. Morrow, and G.A. Baker Child development following in utero exposure: levetiracetam vs sodium valproate Neurology 76 2011 383 389
48. C. Nadebaum, V. Anderson, F. Vajda, D. Reutens, S. Barton, and A. Wood The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy J Int Neuropsychol Soc 17 2011 133 142
49. C. Nadebaum, V.A. Anderson, F. Vajda, D.C. Reutens, S. Barton, and A.G. Wood Language skills of school-aged children prenatally exposed to antiepileptic drugs Neurology 76 2011 719 726
50. C. Cummings, M. Stewart, M. Stevenson, J. Morrow, and J. Nelson Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine Arch Dis Child 96 2011 643 647
51. S.J. Moore, P. Turnpenny, A. Quinn, D.J. Glover, T. Lloyd, and Montgomery A clinical study of 57 children with fetal anticonvulsant syndromes J Med Genet 37 2000 489 497
52. G. Williams, J. King, M. Cunningham, M. Stephan, B. Kerr, and J.H. Hersh Fetal valproate syndrome and autism: additional evidence of an association Dev Med Child Neurol 43 2001 202 206
53. R. Ackers, F.M. Besag, A. Wade, M.L. Murray, and I.C. Wong Changing trends in antiepileptic drug prescribing in girls of child-bearing potential Arch Dis Child 94 2009 443 447
54. T. Rihtman, S. Parush, and A. Ornoy Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function Reprod Toxicol 41 2013 115 125
55. G. Veiby, A.K. Daltveit, S. Schjølberg, C. Stoltenberg, A.S. ∅yen, and S.E. Vollset Exposure to antiepileptic drugs in utero and child development: a prospective population-based study Epilepsia 54 2013 1462 1472